Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bruker Corp (NQ: BRKR )

63.72 +2.47 (+4.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 624,093
Open 62.22
Bid (Size) 63.72 (3)
Ask (Size) 72.55 (4)
Prev. Close 61.25
Today's Range 61.99 - 64.53
52wk Range 53.79 - 94.86
Shares Outstanding 146,727,377
Dividend Yield 0.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin
From Bruker Corporation
Via Business Wire
Rags to Riches: 3 Nanotech Stocks That Could Make Early Investors Rich
Seemingly everyone wants to think big. With nanotech stocks to buy, it’s all about thinking small in a gargantuan way. 
Via InvestorPlace

Performance

YTD
-11.87%
-11.87%
1 Month
-1.26%
-1.26%
3 Month
-29.42%
-29.42%
6 Month
-10.73%
-10.73%
1 Year
-15.04%
-15.04%

More News

Read More
Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
From Bruker Corporation
Via Business Wire
Peeling Back The Layers: Exploring Bruker Through Analyst Insights
Via Benzinga
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
From Bruker Corporation
Via Business Wire
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at Upcoming Investor Conferences
From Bruker Corporation
Via Business Wire
Why Bruker (BRKR) Shares Are Falling During Thursday's Session
Via Benzinga
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference
From Biognosys AG
Via GlobeNewswire
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
From Biognosys AG
Via GlobeNewswire
Bruker Announces Pricing of Public Offering of Common Stock
From Bruker Corporation
Via Business Wire
Bruker Announces Public Offering of Common Stock
From Bruker Corporation
Via Business Wire
Access Reminder for Bruker Investor Webinar on May 17, 2024
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
Bruker Corporation to Host Investor Webinar on May 17, 2024
From Bruker Corporation
Via Business Wire
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
From Bruker Corporation
Via Business Wire
Bruker Completes Asset Acquisition of NanoString Business
From Bruker Corporation
Via Business Wire
Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024)
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BRKR Stock Earnings: Bruker Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
From Bruker Corporation
Via Business Wire
Bruker Reports First Quarter 2024 Financial Results
From Bruker Corporation
Via Business Wire
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.